BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 31377088)

  • 1. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
    Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
    Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
    Ku L; Bysshe T; Steinmetz E; Bruen BK
    Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State Medicaid expansion decisions and disparities in women's cancer screening.
    Sabik LM; Tarazi WW; Bradley CJ
    Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical and colorectal cancer screening prevalence before and after Affordable Care Act Medicaid expansion.
    Huguet N; Angier H; Rdesinski R; Hoopes M; Marino M; Holderness H; DeVoe JE
    Prev Med; 2019 Jul; 124():91-97. PubMed ID: 31077723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women.
    Sabatino SA; Thompson TD; Miller JW; Breen N; White MC; Breslau E; Shoemaker ML
    J Womens Health (Larchmt); 2019 Jul; 28(7):910-918. PubMed ID: 30265611
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.
    Carney PA; O'Malley J; Buckley DI; Mori M; Lieberman DA; Fagnan LJ; Wallace J; Liu B; Morris C
    Cancer; 2012 Dec; 118(24):6217-25. PubMed ID: 22648383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 8. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization.
    Dietrich AJ; Tobin JN; Cassells A; Robinson CM; Reh M; Romero KA; Flood AB; Beach ML
    Ann Fam Med; 2007; 5(4):320-7. PubMed ID: 17664498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act.
    Carlos RC; Fendrick AM; Kolenic G; Kamdar N; Kobernik E; Bell S; Dalton VK
    J Am Coll Radiol; 2019 Jun; 16(6):788-796. PubMed ID: 30833168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Qin J; Shahangian S; Saraiya M; Holt H; Gagnon M; Sawaya GF
    Gynecol Oncol; 2021 Nov; 163(2):378-384. PubMed ID: 34507826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Cancer Screening for Low-income Adults Under the Affordable Care Act Medicaid Expansion.
    Hendryx M; Luo J
    Med Care; 2018 Nov; 56(11):944-949. PubMed ID: 30199428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer.
    Fedewa SA; Goodman M; Flanders WD; Han X; Smith RA; M Ward E; Doubeni CA; Sauer AG; Jemal A
    Cancer; 2015 Sep; 121(18):3272-80. PubMed ID: 26042576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of access in Hispanic cancer screening disparities.
    Spencer JC; Noel L; Shokar NK; Pignone MP
    Cancer; 2023 May; 129(10):1569-1578. PubMed ID: 36787126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women with Visual Impairment and Insured by Medicaid or Medicare Are Less Likely to Receive Recommended Screening for Breast and Cervical Cancers.
    Xu X; Mann JR; McDermott SW; Deroche CB; Gustafson E; Hardin JW
    Ophthalmic Epidemiol; 2017 Jun; 24(3):168-173. PubMed ID: 27552166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016.
    Khushalani JS; Ekwueme DU; Richards TB; Sabatino SA; Guy GP; Zhang Y; Tangka F
    J Womens Health (Larchmt); 2020 Mar; 29(3):327-337. PubMed ID: 31613693
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older.
    DuBard CA; Schmid D; Yow A; Rogers AB; Lawrence WW
    Arch Intern Med; 2008 Oct; 168(18):2014-21. PubMed ID: 18852404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-payment policies and breast and cervical cancer screening in Medicaid.
    Sabik LM; Vichare AM; Dahman B; Bradley CJ
    Am J Manag Care; 2020 Feb; 26(2):69-74. PubMed ID: 32059094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Insurance Coverage Mandates: Colorectal Cancer Screening in the Post-ACA Era.
    Preston MA; Ross L; Chukmaitov A; Smith SA; Odlum ML; Dahman B; Sheppard VB
    Cancer Prev Res (Phila); 2021 Jan; 14(1):123-130. PubMed ID: 32917646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.